Cancer Epidemiologists are crucial in understanding the distribution, determinants, and prevention of cancer across populations. They investigate how various factors—such as genetics, environment, lifestyle, and social conditions—affect cancer risk and outcomes. By analyzing population-level data from cancer registries, clinical studies, and public health records, they identify trends in incidence, mortality, and survival rates. Their work has led to significant discoveries, such as the link between tobacco use and lung cancer or ultraviolet exposure and skin cancer. These insights help develop targeted prevention strategies, influence screening guidelines, and shape evidence-based public health policies aimed at reducing the cancer burden.
Cancer epidemiologists also study disparities in cancer care and outcomes, focusing on how socioeconomic status, race, and geographic location influence disease prevalence and survival. With the rise of molecular and genetic epidemiology, they now integrate biological markers and genomic data to uncover deeper insights into cancer development. Their findings are essential for creating early detection tools, improving access to care, and tailoring interventions to high-risk groups. Cancer epidemiologists collaborate with oncologists, policymakers, and global health organizations to translate research into impactful public health actions. Their efforts contribute to both individual patient outcomes and broader societal change, driving initiatives that aim to prevent cancer before it starts and improve the quality of life for those affected. As cancer continues to evolve, the role of cancer epidemiologists remains vital in crafting a smarter, data-driven response to this global health challenge.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China